SI1789076T1 - Postopki za induciranje melanogeneze pri osebku - Google Patents

Postopki za induciranje melanogeneze pri osebku

Info

Publication number
SI1789076T1
SI1789076T1 SI200532052A SI200532052A SI1789076T1 SI 1789076 T1 SI1789076 T1 SI 1789076T1 SI 200532052 A SI200532052 A SI 200532052A SI 200532052 A SI200532052 A SI 200532052A SI 1789076 T1 SI1789076 T1 SI 1789076T1
Authority
SI
Slovenia
Prior art keywords
subject
methods
inducing melanogenesis
melanogenesis
inducing
Prior art date
Application number
SI200532052A
Other languages
English (en)
Inventor
Michael John Kleinig
Thomas R. Tice
Jay K. Staas
Original Assignee
Clinuvel Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinuvel Pharmaceuticals Limited filed Critical Clinuvel Pharmaceuticals Limited
Publication of SI1789076T1 publication Critical patent/SI1789076T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200532052A 2004-08-04 2005-02-11 Postopki za induciranje melanogeneze pri osebku SI1789076T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59914304P 2004-08-04 2004-08-04
PCT/AU2005/000181 WO2006012667A1 (en) 2004-08-04 2005-02-11 Methods of inducing melanogenesis in a subject.
EP05706231.7A EP1789076B1 (en) 2004-08-04 2005-02-11 Methods of inducing melanogenesis in a subject.

Publications (1)

Publication Number Publication Date
SI1789076T1 true SI1789076T1 (sl) 2016-07-29

Family

ID=35786800

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200532052A SI1789076T1 (sl) 2004-08-04 2005-02-11 Postopki za induciranje melanogeneze pri osebku

Country Status (11)

Country Link
US (3) US9345911B2 (sl)
EP (1) EP1789076B1 (sl)
JP (1) JP5208504B2 (sl)
CN (1) CN101076314A (sl)
AU (1) AU2005269244B2 (sl)
CA (1) CA2575866C (sl)
DK (1) DK1789076T3 (sl)
ES (1) ES2566801T3 (sl)
NZ (1) NZ582130A (sl)
SI (1) SI1789076T1 (sl)
WO (1) WO2006012667A1 (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9345911B2 (en) * 2004-08-04 2016-05-24 Clinuvel Pharmaceuticals Limited Methods of inducing melanogenesis in a subject
JP5449673B2 (ja) * 2004-10-08 2014-03-19 クリヌベール、ファーマスーティカルズ、リミテッド 対象者におけるメラニン形成を誘導するための組成物および方法
EP2056854A4 (en) * 2006-08-28 2011-09-14 Clinuvel Pharmaceuticals Ltd METHOD FOR REDUCING THE INCIDENCE OR SPEED OF SKIN CANCER DEVELOPMENT AND ASSOCIATED PATHOLOGIES
PT2056855E (pt) * 2006-08-31 2014-12-12 Clinuvel Pharmaceuticals Ltd Derivados de alfa-msh para o tratamento de fotodermatoses
SI2957292T1 (sl) 2008-03-27 2018-04-30 Clinuvel Pharmaceuticals Limited Terapija za vitiligo
WO2009152079A1 (en) 2008-06-09 2009-12-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EA020959B1 (ru) 2009-06-08 2015-03-31 Палатин Текнолоджиз, Инк. Пептиды, специфичные к меланокортиновым рецепторам
NZ599774A (en) 2009-11-23 2014-11-28 Palatin Technologies Inc Melanocortin-1 receptor-specific cyclic peptides
CA2781405A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific linear peptides
US8979797B2 (en) * 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
EP2487185A1 (en) 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
WO2015063099A1 (en) 2013-10-28 2015-05-07 Clinuvel Ag Alpha-msh analogues for use in the treatment of hailey-hailey disease
WO2015063102A1 (en) 2013-10-28 2015-05-07 Clinuvel Ag Alpha-msh analogues for use in bullous disease
WO2015067503A1 (en) 2013-11-07 2015-05-14 Clinuvel Ag Alpha-msh analogues for use in the treatment of psoriasis
US20170304406A1 (en) 2014-10-28 2017-10-26 Clinuvel Ag New indication for alpha-msh analogues
EP3212220A1 (en) 2014-10-28 2017-09-06 Clinuvel AG Inflammatory disease
EP3088417A1 (en) 2015-04-28 2016-11-02 Vallaurix Pte. Ltd. Pharmaceutical compound
EP3088418A1 (en) 2015-04-28 2016-11-02 Vallaurix Pte. Ltd. Pharmaceutical compound
WO2018142318A1 (en) 2017-02-01 2018-08-09 Clinuvel Pharmaceuticals Ltd Alpha-msh analogues used in the treatment of xeroderma pigmentosum
CN113546035A (zh) * 2020-04-23 2021-10-26 克林维尔制药有限公司 具有圆柱形形状的药物植入物装置及多部分套件

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
JPH0611710B2 (ja) * 1984-10-19 1994-02-16 ユニバ−シティ パテンツ，インコ−ポレイティド アルファ―ｍｓｈ類似体を含有する製薬組成物
DE3783541T2 (de) * 1986-02-03 1993-06-17 University Patents Inc Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
US5049547A (en) * 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
EP1212061B1 (en) * 1999-08-27 2004-10-27 Southern Research Institute Injectable buprenorphine microparticle compositions and their use in reducing consumption of heroin and alcohol
US9345911B2 (en) * 2004-08-04 2016-05-24 Clinuvel Pharmaceuticals Limited Methods of inducing melanogenesis in a subject

Also Published As

Publication number Publication date
JP5208504B2 (ja) 2013-06-12
US20080305152A1 (en) 2008-12-11
US20180360919A1 (en) 2018-12-20
US20160235819A1 (en) 2016-08-18
EP1789076A4 (en) 2011-08-10
US10857208B2 (en) 2020-12-08
NZ582130A (en) 2011-11-25
WO2006012667A1 (en) 2006-02-09
AU2005269244B2 (en) 2010-12-09
AU2005269244A1 (en) 2006-02-09
CA2575866C (en) 2018-07-10
EP1789076A1 (en) 2007-05-30
CN101076314A (zh) 2007-11-21
ES2566801T3 (es) 2016-04-15
US10076555B2 (en) 2018-09-18
CA2575866A1 (en) 2006-02-09
EP1789076B1 (en) 2016-01-20
US9345911B2 (en) 2016-05-24
JP2008508324A (ja) 2008-03-21
DK1789076T3 (en) 2016-04-11

Similar Documents

Publication Publication Date Title
EP1789076A4 (en) METHODS FOR INDUCING MELANOGENESIS IN A SUBJECT
EP1812034A4 (en) COMPOSITIONS AND METHODS OF INDUCING MELANOESEES IN ONE PERSON
EP1709889A4 (en) CHAIR
GB2412298B (en) Barbecue
ZAA200500513S (en) Chairs
AU302836S (en) Chair
SG119251A1 (en) Methods
ZAA200500260S (en) Chairs
GB0424552D0 (en) Methods and means
GB0403629D0 (en) Methods
GB0403847D0 (en) Methods and means
GB0423552D0 (en) Methods
GB0415805D0 (en) Chair
GB0421911D0 (en) Methods and means
GB0415757D0 (en) Methods
GB0411026D0 (en) Concept fifteen
GB0426632D0 (en) Methods
GB0413206D0 (en) Methods
GB0406479D0 (en) Methods
GB0403966D0 (en) Methods
GB0401514D0 (en) Methods
SG120191A1 (en) Methods
GB0401085D0 (en) Methods
GB0416224D0 (en) Easy rockeries
GB0414361D0 (en) Privatise easy